[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[SANET-MG] Beta conglycinin enriched soy beans from Monsanto
Beta conglycinin has been described as a major soy allergen in a
number of publications. I presume that this new soy production will be
accompanied by a huge sale of anti allergen drugs produced by guess who?
Monsanto's pioneering efforts to develop foods that do not taste will
certainly not go unrewarded. Tasteless foods will certainly cut back on
obesity. Monsanto a champion of glop foods for the masses!
News Headlines Science & Nutrition
Monsanto, Solae to create new soy protein line
10/28/2005- Biotech giant Monsanto and soy ingredients supplier Solae
are to develop a new line of soy proteins that they claim will have a
better taste and higher level of solubility than any other soy protein
on the market, it emerged yesterday.
According to the two companies, the secret lies in the use of a soybean
that has high levels of beta-conglycinin, a naturally occurring,
texture- and flavor-improving compound.
Using plant breeding technology, Monsanto is to develop the new soybean,
and Solae will then isolate the protein from the beans and refine it to
best suit the needs of a variety of applications, including meat, and
“The new soybean will allow us to produce a protein that will have
virtually no taste and better functionality, such as improved binding
properties. This will make it more accessible to a number of
manufacturers who do not currently use soy protein as it is not
compatible with their products,” said Andrew Shea of Solae.
“And because of the health benefits of soy this will allow companies to
produce healthier products, in line with increased consumer demand for
these products,” he told FoodNavigator-USA.com.
Global recognition of soy's potential health benefits has recently
gathered pace. The US Food and Drug Administration has said that soy can
reduce the risk of heart disease when included in a diet low in
saturated fat and cholesterol.
A variety of studies completed last year have also suggested soy may
help to reduce the risk and spread of both prostate and breast cancer as
well as stall the development of type 2 diabetes.
Recent data revealed by market researcher Freedonia suggests that health
claims will contribute to a 5.1 percent annual growth in demand for soy
in the US over the next five years.
Soy protein products are also expected to steam ahead with 5.9 percent
Solae said the new soy protein line will be made from non genetically
modified soybeans, but added that the technology can also be used with
GM soybeans, and modifications can be made depending on individual
According to Monsanto, one of the reasons for the new soybean’s improved
properties is that because beta-conglycinin is a soluble protein,
elevating levels of this in soybeans makes the soy protein more soluble,
improving the texture.
“Beta conglycinin also does not bind flavors, so at higher levels it
does not hold in the bean taste, creating a more neutral taste profile
that can better hold flavorings that are added to the end product,” said
Monsanto’s Christopher Horner.
The new soybean will be available for planting in 2007, with the soy
protein expected to hit the market both in the US and internationally in
the next two to three years.
To unsubscribe from SANET-MG:
1- Visit http://lists.sare.org/archives/sanet-mg.html to unsubscribe or;
2- Send a message to <firstname.lastname@example.org> from the address subscribed to the list. Type "unsubscribe sanet-mg" in the body of the message.
Visit the SANET-MG archives at: http://lists.sare.org/archives/sanet-mg.html
For more information on grants and other resources available through the SARE program, please visit http://www.sare.org.